Literature DB >> 19166731

Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus.

Xiang Li1, Zhiliang Xu, Xin Lu, Xuehui Yang, Peiyuan Yin, Hongwei Kong, Ying Yu, Guowang Xu.   

Abstract

Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry (GCxGC-TOFMS) coupled with pattern recognition methods was applied to analyze plasma from diabetic patients and healthy controls. After sample preparation and GCxGC-TOFMS analysis, collected data were transformed, the peak alignment between different chromatograms was performed to generate the metabolites' peak table, then orthogonal signal correction filtered partial least-squares discriminant analysis (OSC-PLSDA) was carried out to model the data and discover metabolites with a significant concentration change in diabetic patients. With the method above, diabetic patients and healthy controls could be correctly distinguished based on the metabolic abnormity in plasma. Five potential biomarkers including glucose, 2-hydroxyisobutyric acid, linoleic acid, palmitic acid and phosphate were identified. It was found that elevated free fatty acids were essential pathophysiological factors in diabetes mellitus which reflected either the hyperglycemia or the deregulation of fatty acids metabolism. These potential biomarkers in plasma, e.g. palmitic acid, linoleic acid and 2-hydroxybutyric acid might be helpful in the diagnosis or further study of diabetes mellitus. This study shows the practicability and advantage of GCxGC-TOFMS coupled with data analysis and mining for metabonomics in biomarker discovery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19166731     DOI: 10.1016/j.aca.2008.11.058

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  59 in total

1.  DISCO: distance and spectrum correlation optimization alignment for two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics.

Authors:  Bing Wang; Aiqin Fang; John Heim; Bogdan Bogdanov; Scott Pugh; Mark Libardoni; Xiang Zhang
Journal:  Anal Chem       Date:  2010-06-15       Impact factor: 6.986

Review 2.  Mass spectrometry strategies in metabolomics.

Authors:  Zhentian Lei; David V Huhman; Lloyd W Sumner
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

3.  An optimal peak alignment for comprehensive two-dimensional gas chromatography mass spectrometry using mixture similarity measure.

Authors:  Seongho Kim; Aiqin Fang; Bing Wang; Jaesik Jeong; Xiang Zhang
Journal:  Bioinformatics       Date:  2011-04-14       Impact factor: 6.937

Review 4.  Metabolomics in human type 2 diabetes research.

Authors:  Jingyi Lu; Guoxiang Xie; Weiping Jia; Wei Jia
Journal:  Front Med       Date:  2013-02-02       Impact factor: 4.592

5.  Metabolomics as a tool to evaluate the toxicity of formulations containing amphotericin B, an antileishmanial drug.

Authors:  Délia C M Santos; Marta L Lima; Juliano S Toledo; Paula A Fernandes; Marta M G Aguiar; Ángeles López-Gonzálvez; Lucas A M Ferreira; Ana Paula Fernandes; Coral Barbas
Journal:  Toxicol Res (Camb)       Date:  2016-10-12       Impact factor: 3.524

Review 6.  Review of recent developments in GC-MS approaches to metabolomics-based research.

Authors:  David J Beale; Farhana R Pinu; Konstantinos A Kouremenos; Mahesha M Poojary; Vinod K Narayana; Berin A Boughton; Komal Kanojia; Saravanan Dayalan; Oliver A H Jones; Daniel A Dias
Journal:  Metabolomics       Date:  2018-11-17       Impact factor: 4.290

Review 7.  Metabolomics in Bariatric Surgery: Towards Identification of Mechanisms and Biomarkers of Metabolic Outcomes.

Authors:  Jane Ha; Yeongkeun Kwon; Sungsoo Park
Journal:  Obes Surg       Date:  2021-07-27       Impact factor: 4.129

Review 8.  Lab-on-a-chip electrical multiplexing techniques for cellular and molecular biomarker detection.

Authors:  Fan Liu; Liwei Ni; Jiang Zhe
Journal:  Biomicrofluidics       Date:  2018-04-10       Impact factor: 2.800

9.  Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approach.

Authors:  Marianna Lucio; Agnes Fekete; Cora Weigert; Brigitte Wägele; Xinjie Zhao; Jing Chen; Andreas Fritsche; Hans-Ulrich Häring; Erwin D Schleicher; Guowang Xu; Philippe Schmitt-Kopplin; Rainer Lehmann
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

10.  Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting.

Authors:  Karsten Suhre; Christa Meisinger; Angela Döring; Elisabeth Altmaier; Petra Belcredi; Christian Gieger; David Chang; Michael V Milburn; Walter E Gall; Klaus M Weinberger; Hans-Werner Mewes; Martin Hrabé de Angelis; H-Erich Wichmann; Florian Kronenberg; Jerzy Adamski; Thomas Illig
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.